Cargando…

SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model

SARS-CoV-2 variants of concern (VOC) have triggered infection waves. Oral antivirals such as molnupiravir promise to improve disease management, but efficacy against VOC delta was questioned and potency against omicron is unknown. This study evaluates molnupiravir against VOC in human airway epithel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lieber, Carolin M., Cox, Robert M., Sourimant, Julien, Wolf, Josef D., Juergens, Kate, Phung, Quynh, Saindane, Manohar T., Smith, Meghan K., Sticher, Zachary M., Kalykhalov, Alexander A., Natchus, Michael G., Painter, George R., Sakamoto, Kaori, Greninger, Alexander L., Plemper, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338273/ https://www.ncbi.nlm.nih.gov/pubmed/35906230 http://dx.doi.org/10.1038/s41467-022-32045-1

Ejemplares similares

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
por: Cox, Robert M., et al.
Publicado: (2023)

4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses
por: Lieber, Carolin M., et al.
Publicado: (2023)

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication
por: Sourimant, Julien, et al.
Publicado: (2021)

Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase
por: Sourimant, Julien, et al.
Publicado: (2022)

Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity
por: Cox, Robert M., et al.
Publicado: (2021)

Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
por: Painter, George R, et al.
Publicado: (2021)

Orally Efficacious Broad-Spectrum Allosteric Inhibitor of Paramyxovirus Polymerase
por: Cox, Robert M, et al.
Publicado: (2020)

Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex
por: Sourimant, Julien, et al.
Publicado: (2016)

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Asymmetric synthesis of host-directed inhibitors of myxoviruses
por: Moore, Terry W, et al.
Publicado: (2013)

The Evolution of Widespread Recombination Suppression on the Dwarf Hamster (Phodopus) X Chromosome
por: Moore, Emily C., et al.
Publicado: (2022)

Progress and pitfalls of a year of drug repurposing screens against COVID-19()
por: Sourimant, Julien, et al.
Publicado: (2021)

Analysis of the Potential for N(4)-Hydroxycytidine To Inhibit Mitochondrial Replication and Function
por: Sticher, Zachary M., et al.
Publicado: (2020)

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

The complete mitogenome of Sokolov’s Dwarf Hamster (Cricetulus sokolovi) and implication of phylogenetic status
por: Qin, Boxin, et al.
Publicado: (2021)

Viral evolution identifies a regulatory interface between paramyxovirus polymerase complex and nucleocapsid that controls replication dynamics
por: Sourimant, Julien, et al.
Publicado: (2020)

Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding
por: Wittwer, Kevin, et al.
Publicado: (2021)

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Females choose gentle, but not healthy or macho males in Campbell dwarf hamsters (Phodopus campbelli Thomas 1905)
por: Rogovin, Konstantin A., et al.
Publicado: (2017)

Chromosome Synapsis and Recombination in Male-Sterile and Female-Fertile Interspecies Hybrids of the Dwarf Hamsters (Phodopus, Cricetidae)
por: Bikchurina, Tatiana I., et al.
Publicado: (2018)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023)

Two Novel Iflaviruses Discovered in Bat Samples in Washington State
por: Juergens, Kate B., et al.
Publicado: (2022)

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
por: Squires, Katherine E., et al.
Publicado: (2020)

Concise two-step chemical synthesis of molnupiravir
por: Pereira, Vinícius R. D., et al.
Publicado: (2022)

Vascularite rétinienne post-Covid-19 et Molnupiravir
por: Lassouli, I., et al.
Publicado: (2022)

Effect of Exercise on Photoperiod-Regulated Hypothalamic Gene Expression and Peripheral Hormones in the Seasonal Dwarf Hamster Phodopus sungorus
por: Petri, Ines, et al.
Publicado: (2014)

Publisher Correction: Molnupiravir: coding for catastrophe
por: Malone, Brandon, et al.
Publicado: (2021)

Molnupiravir, une affaire franco-européenne
por: Manus, Jean-Marie
Publicado: (2021)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Why Molnupiravir Fails in Hospitalized Patients
por: Brown, Ashley N., et al.
Publicado: (2022)

Small-Molecule Antiviral β-d-N(4)-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
por: Agostini, Maria L., et al.
Publicado: (2019)

PANORAMIC: important insights into molnupiravir use in COVID-19
por: Kidd, Michael R, et al.
Publicado: (2023)

Small RNA-seq and hormones in the testes of dwarf hamsters (Cricetulus barabensis) reveal the potential pathways in photoperiod regulated reproduction()
por: Wang, Shuo, et al.
Publicado: (2023)

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2
por: Holman, Wendy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_757spstmlktjt6l0egquij5f30